Invention Grant
- Patent Title: Biological production of thymidine
- Patent Title (中): 生物制作胸苷
-
Application No.: US12278227Application Date: 2007-02-05
-
Publication No.: US08263384B2Publication Date: 2012-09-11
- Inventor: David Martin Anderson , Andrew John Collis , Lin Liu , Sergey Podkovyrov , Christopher Preston
- Applicant: David Martin Anderson , Andrew John Collis , Lin Liu , Sergey Podkovyrov , Christopher Preston
- Applicant Address: GB Greenford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford, Middlesex
- Agent Michael M. Conger
- Priority: GB0602339.4 20060206
- International Application: PCT/EP2007/051072 WO 20070205
- International Announcement: WO2007/090810 WO 20070816
- Main IPC: C12N1/21
- IPC: C12N1/21 ; C12P19/38

Abstract:
Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e.g. T4 frd; Serine Hydroxymethyltransferase genes e.g. glyA; 3-phosphoglycerate dehydrogenase genes e.g. serA; and THF synthase genes e.g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.
Public/Granted literature
- US20090081735A1 NOVEL PROCESS Public/Granted day:2009-03-26
Information query
IPC分类: